Jiang, L., Xu, W., Chen, Y., & Zhang, Y. SHP2 inhibitor specifically suppresses the stemness of KRAS-mutant non-small cell lung cancer cells. Taylor & Francis Group.
Chicago Style (17th ed.) CitationJiang, Lei, Weiping Xu, Yi Chen, and Yue Zhang. SHP2 Inhibitor Specifically Suppresses the Stemness of KRAS-mutant Non-small Cell Lung Cancer Cells. Taylor & Francis Group.
MLA (9th ed.) CitationJiang, Lei, et al. SHP2 Inhibitor Specifically Suppresses the Stemness of KRAS-mutant Non-small Cell Lung Cancer Cells. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.